Skip to content
Research Article Open access CC BY 4.0

In Silico ADME/T Properties of Quinine Derivatives using SwissADME and pkCSM Webservers

Jean Gonfi M. Mvondo, Aristote Matondo, Dani T. Mawete, Sylvie-Mireille N. Bambi, Blaise M. Mbala, Pierre O. Lohohola

International Journal of TROPICAL DISEASE & Health · pp. 1–12 · Published 3 Aug 2021

10.9734/ijtdh/2021/v42i1130492

Abstract

Aim: Malaria is among the most devastating and widespread tropical parasitic diseases. To overcome antimalarial drug resistance, new drugs need to be developed. This study is designed to establish the pharmacokinetic profile and toxicity of nine quinine derivatives as potential antimalarial drugs using in silico approaches by SwissADME and pkCSM. Methodology: The structures of investigated compounds were translated into canonical SMILES format and then submitted to SwissADME web tool that gives free access to physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness of compounds, and pkCSM webserver for predicting and optimizing pharmacokinetic and toxicity properties. Results: SwissADME mainly used to predict the physicochemical properties of compounds and their drug-likeness revealed that all quinine derivatives have good bioavailability and satisfied the Lipinski’s rule of five. The pkCSM results on the absorption, distribution, metabolism, excretion and toxicity show  that all investigated compounds have a good pharmacokinetic profile and they are safe since they belong to class 4 of the Globally Harmonized System (300 < Category 4 ≤ 2000 mg/kg/day). Conclusion: Drug-likeness and ADME/T predictions of nine investigated quinine derivatives revealed that they are good candidates to oral drug formulation and thus they can be used in a broader context of overcoming the development of resistance by Plasmodium protozoans against most of the drugs currently used to treat malaria. As future prospects, further studies on bioevaluation of compounds are needed to elucidate their potential pharmacological activities.

Quinine derivatives malaria pharmacokinetic profile SwissADME pkCSM

Cited by 80

Sennoside A from Cassia angustifolia as a mixed-type inhibitor of DPP-IV: Integrative in vitro, in silico, and kinetic characterization

Srishti Chhabria, Shivangi Mathur, Sebastian Vadakan · Biochemical and Biophysical Research Communications · 2025

Ligand-based virtual screening and QSAR modelling for the discovery of potent SmHDAC8 inhibitors

Saudatu Chinade Ja’afaru, Adamu Uzairu, Renato Araújo da Costa · In Silico Research in Biomedicine · 2025

Therapeutic potential of Salvia hispanica seed extract in alloxan-induced diabetic mice: phytochemical, biochemical, histological, and in silico approaches

Nauman Ahmad, Shazia Khurshid, Muhammad Wajid · Journal of Food Measurement and Characterization · 2025

Memory-Enhancing Effects of Dauricine in Swiss Mice: Possible Molecular Interventions Through In Vivo and In Silico Studies

Md. Showkot Akbor, Md. Sakib Al Hasan, Mst. Farjanamul Haque · NeuroMolecular Medicine · 2025

CUD003, a Novel Curcumin Derivative, Ameliorates LPS-Induced Impairment of Endothelium-Dependent Relaxation and Vascular Inflammation in Mice

Hirokazu Matsuzaki, Anna Arai, Meiyan Xuan · International Journal of Molecular Sciences · 2025

Piperidines as dual inhibitors of tyrosinase and pancreatic lipase: in vitro and in silico mechanistic insights

Nafeesa Naeem, Ehsan Ullah Mughal, Bushra Shakoor · Future Medicinal Chemistry · 2025

Showing 20 of 80 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

80

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.